Spine Align Raises $1.75M in Seed Funding


Spine Align, LLC, a Baltimore, MD-based medical device company developing a portfolio of products that enable spine surgeons to measure, visualize, and adjust patients’ spinal alignment during surgery, closed a $1.75M seed funding round.

The round was led by the Rockies Venture Club, with additional support by members of the Berkeley Angel Network, NO/LA Angel Network, Pasadena Angels, Bellingham Angels, the Abell Foundation, and VentureWell.

This round supports development efforts to achieve FDA 510(k) clearance for their flagship product, LiveAlignTM, in 2021.

Co-founded by Amir Soltanianzadeh, CEO, Dr. David Gullotti, CTO, and Dr. Nicholas Theodore, Spine Align is a company developing a portfolio of intraoperative products that both assess and assist with corrective surgeries for spinal alignment. The venture originated as a spinout from the Johns Hopkins Center for Bioengineering Innovation and Design.



Join the discussion